RecruitingNot ApplicableNCT07129811

Stellate Ganglion Block in Complex Regional Pain Syndrome

The Effect of Ultrasound-Guided Stellate Ganglion Block on Pain, Functionality, and Quality of Life in Type 1 Complex Regional Pain Syndrome in Stroke Patients


Sponsor

Ankara City Hospital Bilkent

Enrollment

32 participants

Start Date

Jan 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim was to investigate the effect of Stellate Ganglion Blockade, which will be applied in addition to conventional physical therapy, on pain and functionality in patients with poststroke complex regional pain syndrome.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria3

  • Volunteer male and female patients aged 18-75
  • Diagnosed with Complex Regional Pain Syndrome according to the IASP 2012 Diagnostic Criteria
  • Patient's pain level must be VAS \>4

Exclusion Criteria6

  • Presence of existing neurological diseases other than rheumatic diseases and stroke
  • General impairment
  • Conditions that would constitute a contraindication to application, such as an open wound or sensory deficit in the application area
  • Presence of active infection
  • Presence of malignancy
  • Cognitive dysfunction (mini mental test result \<23)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREStellate Ganglion Block

The stellate ganglion is located in front of the anterior tubercle of the C6 vertebra. An ultrasound-guided intervention will be performed from the affected side and 2 cc of 1% lidocaine will be injected.


Locations(1)

Ankara Bilkent City Hospital

Ankara, Çankaya, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07129811


Related Trials